| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cross Infection | 79 | 2019 | 1428 | 4.050 |
Why?
|
| Infection Control | 29 | 2019 | 980 | 2.300 |
Why?
|
| Quality Improvement | 20 | 2019 | 3808 | 1.930 |
Why?
|
| Hospitals, Pediatric | 31 | 2013 | 1791 | 1.530 |
Why?
|
| Staphylococcal Infections | 33 | 2019 | 1405 | 1.480 |
Why?
|
| Intensive Care Units, Neonatal | 28 | 2019 | 797 | 1.210 |
Why?
|
| Bacteremia | 19 | 2015 | 961 | 1.120 |
Why?
|
| Tracheotomy | 4 | 2011 | 166 | 1.020 |
Why?
|
| Quality of Health Care | 24 | 2020 | 4385 | 0.990 |
Why?
|
| Medication Errors | 11 | 2010 | 799 | 0.940 |
Why?
|
| Quality Assurance, Health Care | 14 | 2018 | 2215 | 0.920 |
Why?
|
| Latent Tuberculosis | 5 | 2024 | 230 | 0.900 |
Why?
|
| Drug Resistance, Multiple | 6 | 2012 | 254 | 0.870 |
Why?
|
| Surgical Wound Infection | 15 | 2018 | 1552 | 0.810 |
Why?
|
| Respiratory Tract Infections | 8 | 2008 | 980 | 0.800 |
Why?
|
| Catheter-Related Infections | 8 | 2019 | 254 | 0.790 |
Why?
|
| Chlorhexidine | 5 | 2019 | 163 | 0.770 |
Why?
|
| Models, Organizational | 5 | 2018 | 574 | 0.770 |
Why?
|
| Anti-Infective Agents, Local | 8 | 2019 | 250 | 0.750 |
Why?
|
| Staphylococcus epidermidis | 15 | 2015 | 119 | 0.720 |
Why?
|
| Medical Errors | 12 | 2012 | 1296 | 0.710 |
Why?
|
| Diffusion of Innovation | 2 | 2018 | 726 | 0.700 |
Why?
|
| Attitude of Health Personnel | 8 | 2018 | 3871 | 0.650 |
Why?
|
| Drug Resistance, Microbial | 18 | 2008 | 858 | 0.640 |
Why?
|
| Parents | 11 | 2016 | 3448 | 0.630 |
Why?
|
| Catheters, Indwelling | 12 | 2019 | 430 | 0.630 |
Why?
|
| Anti-Bacterial Agents | 36 | 2019 | 7269 | 0.620 |
Why?
|
| Vancomycin | 10 | 2005 | 501 | 0.600 |
Why?
|
| Delivery of Health Care | 7 | 2020 | 5380 | 0.600 |
Why?
|
| Hospitals | 20 | 2019 | 3986 | 0.600 |
Why?
|
| Pediatrics | 15 | 2015 | 3517 | 0.590 |
Why?
|
| Safety Management | 5 | 2015 | 782 | 0.580 |
Why?
|
| Staphylococcus aureus | 15 | 2010 | 1459 | 0.580 |
Why?
|
| Evidence-Based Practice | 3 | 2018 | 503 | 0.560 |
Why?
|
| Disinfection | 6 | 2019 | 205 | 0.550 |
Why?
|
| Epidemiologic Methods | 7 | 2017 | 1366 | 0.550 |
Why?
|
| Intensive Care, Neonatal | 4 | 2004 | 192 | 0.540 |
Why?
|
| Polysaccharides, Bacterial | 17 | 2007 | 580 | 0.530 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 2 | 2006 | 35 | 0.530 |
Why?
|
| Disease Outbreaks | 7 | 2012 | 1785 | 0.530 |
Why?
|
| Arthroplasty, Replacement | 2 | 2017 | 341 | 0.520 |
Why?
|
| Medical Audit | 6 | 2019 | 466 | 0.520 |
Why?
|
| Cooperative Behavior | 5 | 2017 | 1508 | 0.500 |
Why?
|
| Total Quality Management | 6 | 2003 | 274 | 0.490 |
Why?
|
| Drug Resistance, Bacterial | 8 | 2012 | 1031 | 0.480 |
Why?
|
| Cystic Fibrosis | 14 | 2008 | 1184 | 0.470 |
Why?
|
| Gastrointestinal Diseases | 4 | 2008 | 1185 | 0.460 |
Why?
|
| Catheterization, Central Venous | 7 | 2011 | 516 | 0.460 |
Why?
|
| Staphylococcus | 9 | 2005 | 155 | 0.450 |
Why?
|
| Tuberculosis | 5 | 2024 | 1961 | 0.450 |
Why?
|
| Sepsis | 23 | 2009 | 2604 | 0.450 |
Why?
|
| Infant, Newborn | 63 | 2019 | 25903 | 0.450 |
Why?
|
| Guideline Adherence | 10 | 2017 | 2295 | 0.450 |
Why?
|
| Personnel, Hospital | 5 | 2015 | 288 | 0.440 |
Why?
|
| Hospitalists | 5 | 2007 | 307 | 0.440 |
Why?
|
| Baths | 2 | 2013 | 54 | 0.430 |
Why?
|
| Quality Indicators, Health Care | 9 | 2019 | 1842 | 0.430 |
Why?
|
| Intensive Care Units | 12 | 2019 | 3717 | 0.420 |
Why?
|
| Bacteriological Techniques | 8 | 2008 | 277 | 0.410 |
Why?
|
| Hospitals, Teaching | 8 | 2010 | 1183 | 0.410 |
Why?
|
| Workload | 1 | 2018 | 857 | 0.400 |
Why?
|
| Humans | 271 | 2024 | 752741 | 0.400 |
Why?
|
| Disinfectants | 1 | 2013 | 122 | 0.400 |
Why?
|
| Child, Preschool | 60 | 2022 | 41390 | 0.390 |
Why?
|
| Bacterial Infections | 13 | 2009 | 1401 | 0.390 |
Why?
|
| Acetylglucosamine | 8 | 2010 | 192 | 0.380 |
Why?
|
| Harm Reduction | 1 | 2012 | 132 | 0.380 |
Why?
|
| Hospital Mortality | 10 | 2016 | 5367 | 0.370 |
Why?
|
| Organizational Innovation | 5 | 2018 | 557 | 0.370 |
Why?
|
| Length of Stay | 15 | 2023 | 6355 | 0.370 |
Why?
|
| Causality | 1 | 2017 | 1285 | 0.370 |
Why?
|
| United States | 65 | 2023 | 70772 | 0.360 |
Why?
|
| Antibodies, Bacterial | 10 | 2010 | 1475 | 0.360 |
Why?
|
| Infant | 53 | 2018 | 35447 | 0.350 |
Why?
|
| Child | 82 | 2024 | 78594 | 0.350 |
Why?
|
| Vancomycin Resistance | 5 | 2011 | 128 | 0.350 |
Why?
|
| Blood | 4 | 2008 | 593 | 0.350 |
Why?
|
| Pseudomonas Infections | 5 | 2008 | 608 | 0.350 |
Why?
|
| Sick Role | 1 | 2009 | 237 | 0.330 |
Why?
|
| Salmonella paratyphi A | 1 | 2008 | 47 | 0.330 |
Why?
|
| Paratyphoid Fever | 1 | 2008 | 35 | 0.330 |
Why?
|
| Reimbursement, Incentive | 5 | 2019 | 543 | 0.330 |
Why?
|
| Infant, Newborn, Diseases | 9 | 2004 | 587 | 0.320 |
Why?
|
| Streptococcal Infections | 7 | 2008 | 642 | 0.320 |
Why?
|
| Pharmacists | 2 | 2008 | 256 | 0.320 |
Why?
|
| Methicillin Resistance | 4 | 2007 | 198 | 0.310 |
Why?
|
| Pseudomonas aeruginosa | 8 | 2008 | 1216 | 0.310 |
Why?
|
| Culture Media | 4 | 2008 | 908 | 0.310 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 3 | 2008 | 478 | 0.310 |
Why?
|
| Conscious Sedation | 2 | 2009 | 527 | 0.300 |
Why?
|
| Absenteeism | 2 | 2008 | 251 | 0.300 |
Why?
|
| Program Evaluation | 7 | 2018 | 2502 | 0.290 |
Why?
|
| Salmonella typhi | 1 | 2008 | 199 | 0.290 |
Why?
|
| Psychomotor Agitation | 1 | 2009 | 302 | 0.290 |
Why?
|
| Program Development | 7 | 2018 | 1314 | 0.290 |
Why?
|
| Typhoid Fever | 1 | 2008 | 195 | 0.290 |
Why?
|
| Health Care Surveys | 12 | 2018 | 2454 | 0.290 |
Why?
|
| Bacterial Adhesion | 9 | 2004 | 316 | 0.280 |
Why?
|
| Urinary Tract Infections | 8 | 2019 | 795 | 0.280 |
Why?
|
| Health Care Reform | 3 | 2017 | 1272 | 0.280 |
Why?
|
| Research Support as Topic | 1 | 2011 | 706 | 0.280 |
Why?
|
| Mediastinitis | 2 | 2018 | 47 | 0.280 |
Why?
|
| Emergency Service, Hospital | 11 | 2009 | 7766 | 0.270 |
Why?
|
| Computers | 2 | 2006 | 607 | 0.270 |
Why?
|
| Medical Informatics Applications | 2 | 2005 | 186 | 0.270 |
Why?
|
| Alcohols | 2 | 2005 | 92 | 0.270 |
Why?
|
| Hospital Administration | 3 | 2002 | 353 | 0.270 |
Why?
|
| Interdisciplinary Communication | 2 | 2013 | 948 | 0.270 |
Why?
|
| Gram-Positive Bacterial Infections | 7 | 2011 | 339 | 0.270 |
Why?
|
| Lyme Disease | 3 | 2016 | 621 | 0.260 |
Why?
|
| Critical Illness | 5 | 2014 | 2697 | 0.260 |
Why?
|
| Ketolides | 1 | 2005 | 12 | 0.260 |
Why?
|
| Patient Readmission | 4 | 2013 | 3161 | 0.260 |
Why?
|
| Comparative Effectiveness Research | 1 | 2011 | 693 | 0.260 |
Why?
|
| Practice Guidelines as Topic | 11 | 2015 | 7355 | 0.260 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 1417 | 0.260 |
Why?
|
| Burkholderia Infections | 1 | 2005 | 44 | 0.260 |
Why?
|
| Common Cold | 2 | 2003 | 63 | 0.260 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2007 | 193 | 0.260 |
Why?
|
| Health Services Research | 5 | 2016 | 1838 | 0.260 |
Why?
|
| Professional Role | 1 | 2008 | 312 | 0.260 |
Why?
|
| Medical History Taking | 3 | 2005 | 782 | 0.260 |
Why?
|
| Otitis Externa | 1 | 2004 | 19 | 0.260 |
Why?
|
| Fimbriae, Bacterial | 4 | 1989 | 138 | 0.250 |
Why?
|
| Consultants | 1 | 2005 | 53 | 0.250 |
Why?
|
| Infant Mortality | 6 | 2018 | 763 | 0.250 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 4 | 2019 | 690 | 0.250 |
Why?
|
| Analgesia | 1 | 2009 | 460 | 0.250 |
Why?
|
| Communicable Disease Control | 5 | 2005 | 862 | 0.250 |
Why?
|
| Multimedia | 1 | 2005 | 77 | 0.250 |
Why?
|
| Infant, Low Birth Weight | 7 | 2006 | 856 | 0.240 |
Why?
|
| Rhinovirus | 3 | 2001 | 191 | 0.240 |
Why?
|
| Benchmarking | 4 | 2016 | 1048 | 0.240 |
Why?
|
| Blood Bactericidal Activity | 3 | 2000 | 126 | 0.240 |
Why?
|
| Otitis Media | 2 | 2009 | 284 | 0.230 |
Why?
|
| Health Resources | 2 | 2011 | 920 | 0.230 |
Why?
|
| Insurance Claim Review | 3 | 2018 | 724 | 0.230 |
Why?
|
| Economics, Hospital | 3 | 2018 | 214 | 0.230 |
Why?
|
| Gram-Negative Bacteria | 2 | 2000 | 274 | 0.230 |
Why?
|
| United States Agency for Healthcare Research and Quality | 2 | 2016 | 92 | 0.230 |
Why?
|
| Ambulatory Care | 5 | 2017 | 2738 | 0.230 |
Why?
|
| Clostridium Infections | 1 | 2010 | 552 | 0.230 |
Why?
|
| Case Management | 1 | 2005 | 285 | 0.220 |
Why?
|
| Coagulase | 10 | 1999 | 54 | 0.220 |
Why?
|
| Opsonin Proteins | 6 | 2010 | 150 | 0.220 |
Why?
|
| Enterococcus | 4 | 2011 | 156 | 0.210 |
Why?
|
| Blood Proteins | 4 | 2002 | 1145 | 0.210 |
Why?
|
| Population Surveillance | 7 | 2015 | 2618 | 0.210 |
Why?
|
| Pneumonia, Ventilator-Associated | 3 | 2016 | 277 | 0.210 |
Why?
|
| Health Education | 2 | 2008 | 1064 | 0.210 |
Why?
|
| Patient Discharge | 3 | 2013 | 3356 | 0.210 |
Why?
|
| Escherichia coli Infections | 5 | 2007 | 533 | 0.210 |
Why?
|
| Health Personnel | 4 | 2011 | 3246 | 0.210 |
Why?
|
| Skin Care | 1 | 2002 | 53 | 0.210 |
Why?
|
| Health Maintenance Organizations | 3 | 2007 | 641 | 0.200 |
Why?
|
| Delphi Technique | 3 | 2018 | 798 | 0.200 |
Why?
|
| Picornaviridae Infections | 2 | 2001 | 91 | 0.200 |
Why?
|
| Ethanol | 2 | 2005 | 1346 | 0.200 |
Why?
|
| Pneumonia, Bacterial | 1 | 2004 | 318 | 0.200 |
Why?
|
| Hospital-Physician Relations | 1 | 2001 | 18 | 0.200 |
Why?
|
| Urinary Catheterization | 2 | 2019 | 202 | 0.190 |
Why?
|
| Safety | 4 | 2010 | 1179 | 0.190 |
Why?
|
| Adolescent | 45 | 2024 | 86713 | 0.190 |
Why?
|
| Organizational Culture | 3 | 2011 | 514 | 0.190 |
Why?
|
| Malpractice | 2 | 2017 | 574 | 0.190 |
Why?
|
| Enterococcus faecalis | 5 | 2000 | 250 | 0.190 |
Why?
|
| Hospital Information Systems | 3 | 2011 | 396 | 0.190 |
Why?
|
| Respirovirus Infections | 3 | 1992 | 51 | 0.190 |
Why?
|
| Developing Countries | 4 | 2005 | 2847 | 0.190 |
Why?
|
| Pharyngitis | 3 | 2008 | 218 | 0.180 |
Why?
|
| Escherichia coli | 11 | 2007 | 4248 | 0.180 |
Why?
|
| Risk Management | 4 | 2017 | 563 | 0.180 |
Why?
|
| Research | 4 | 2017 | 2001 | 0.180 |
Why?
|
| Guidelines as Topic | 5 | 2014 | 1402 | 0.180 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2005 | 551 | 0.180 |
Why?
|
| Gloves, Surgical | 2 | 1991 | 26 | 0.180 |
Why?
|
| Equipment Contamination | 8 | 2001 | 184 | 0.180 |
Why?
|
| Povidone-Iodine | 2 | 2001 | 59 | 0.180 |
Why?
|
| Interinstitutional Relations | 1 | 2001 | 238 | 0.170 |
Why?
|
| Disease Transmission, Infectious | 3 | 2019 | 546 | 0.170 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2001 | 340 | 0.170 |
Why?
|
| Tobramycin | 4 | 1999 | 69 | 0.170 |
Why?
|
| Streptococcus pyogenes | 4 | 2008 | 291 | 0.170 |
Why?
|
| Health Care Sector | 1 | 2001 | 193 | 0.170 |
Why?
|
| Staphylococcal Vaccines | 3 | 2005 | 32 | 0.170 |
Why?
|
| Respiratory System Abnormalities | 2 | 2010 | 69 | 0.170 |
Why?
|
| Penicillins | 4 | 2001 | 387 | 0.160 |
Why?
|
| Osteomyelitis | 1 | 2023 | 409 | 0.160 |
Why?
|
| Severity of Illness Index | 11 | 2008 | 15657 | 0.160 |
Why?
|
| Mupirocin | 1 | 2019 | 56 | 0.160 |
Why?
|
| Massachusetts | 15 | 2017 | 8721 | 0.160 |
Why?
|
| Drug Utilization Review | 3 | 2005 | 246 | 0.160 |
Why?
|
| Health Services | 2 | 2008 | 760 | 0.160 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2001 | 143 | 0.160 |
Why?
|
| Vaccines | 3 | 2023 | 842 | 0.160 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2001 | 255 | 0.160 |
Why?
|
| Klebsiella Infections | 2 | 2012 | 139 | 0.160 |
Why?
|
| Learning | 2 | 2018 | 1727 | 0.160 |
Why?
|
| Internship and Residency | 5 | 2009 | 5858 | 0.160 |
Why?
|
| Antisepsis | 2 | 1995 | 18 | 0.150 |
Why?
|
| Bacterial Capsules | 5 | 2000 | 252 | 0.150 |
Why?
|
| Attitude to Health | 3 | 2005 | 2058 | 0.150 |
Why?
|
| Tuberculin Test | 3 | 2022 | 214 | 0.150 |
Why?
|
| Female | 83 | 2022 | 385090 | 0.150 |
Why?
|
| Birth Weight | 6 | 1993 | 2099 | 0.150 |
Why?
|
| Probability | 5 | 2017 | 2514 | 0.150 |
Why?
|
| Housing | 2 | 2000 | 673 | 0.150 |
Why?
|
| Hepatitis B | 2 | 2002 | 702 | 0.150 |
Why?
|
| Insurance Claim Reporting | 2 | 2016 | 161 | 0.150 |
Why?
|
| Antigens, Bacterial | 6 | 2010 | 1177 | 0.150 |
Why?
|
| Spinal Fusion | 1 | 2007 | 1238 | 0.150 |
Why?
|
| Sputum | 6 | 1999 | 480 | 0.150 |
Why?
|
| Risk Factors | 31 | 2023 | 73094 | 0.150 |
Why?
|
| Male | 69 | 2022 | 354311 | 0.150 |
Why?
|
| Patient Care Team | 4 | 2015 | 2555 | 0.150 |
Why?
|
| Multivariate Analysis | 11 | 2013 | 12250 | 0.140 |
Why?
|
| Michigan | 1 | 2017 | 350 | 0.140 |
Why?
|
| Enterococcus faecium | 2 | 1999 | 102 | 0.140 |
Why?
|
| Organizational Case Studies | 1 | 2017 | 304 | 0.140 |
Why?
|
| Virus Diseases | 3 | 2000 | 722 | 0.140 |
Why?
|
| Drug Prescriptions | 6 | 2008 | 1651 | 0.140 |
Why?
|
| Hospital Charges | 2 | 2015 | 367 | 0.140 |
Why?
|
| Catheterization | 6 | 2006 | 1467 | 0.130 |
Why?
|
| Patient Isolation | 3 | 2011 | 100 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 10057 | 0.130 |
Why?
|
| Ticarcillin | 3 | 1986 | 8 | 0.130 |
Why?
|
| Cluster Analysis | 3 | 2017 | 2719 | 0.130 |
Why?
|
| Data Collection | 5 | 2013 | 3350 | 0.130 |
Why?
|
| Health Policy | 3 | 2018 | 2687 | 0.130 |
Why?
|
| Tick-Borne Diseases | 1 | 2015 | 34 | 0.130 |
Why?
|
| Beverages | 1 | 2021 | 818 | 0.130 |
Why?
|
| Haemophilus influenzae | 10 | 1985 | 171 | 0.130 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2014 | 1011 | 0.130 |
Why?
|
| Endocarditis, Bacterial | 3 | 1999 | 459 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 3218 | 0.130 |
Why?
|
| Drug Utilization | 7 | 2008 | 1180 | 0.130 |
Why?
|
| Scalp | 2 | 1988 | 380 | 0.130 |
Why?
|
| Medicare | 6 | 2018 | 6670 | 0.130 |
Why?
|
| Drug Contamination | 4 | 1990 | 148 | 0.130 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2016 | 121 | 0.120 |
Why?
|
| Endoscopes | 2 | 1992 | 175 | 0.120 |
Why?
|
| Adhesins, Bacterial | 4 | 2005 | 120 | 0.120 |
Why?
|
| Academies and Institutes | 1 | 2017 | 320 | 0.120 |
Why?
|
| beta-Glucans | 2 | 2005 | 124 | 0.120 |
Why?
|
| Haemophilus Infections | 6 | 1985 | 95 | 0.120 |
Why?
|
| Blood-Borne Pathogens | 3 | 2011 | 52 | 0.120 |
Why?
|
| Carrier State | 7 | 2019 | 520 | 0.120 |
Why?
|
| Prospective Studies | 19 | 2013 | 53863 | 0.120 |
Why?
|
| Child Day Care Centers | 2 | 2005 | 123 | 0.120 |
Why?
|
| Asthma | 5 | 2009 | 6089 | 0.120 |
Why?
|
| Meningococcal Vaccines | 2 | 2005 | 95 | 0.120 |
Why?
|
| Hepatic Encephalopathy | 1 | 1995 | 142 | 0.120 |
Why?
|
| Fetal Blood | 1 | 2000 | 1332 | 0.120 |
Why?
|
| Adolescent Health Services | 1 | 2016 | 217 | 0.120 |
Why?
|
| Phagocytosis | 8 | 2007 | 1555 | 0.120 |
Why?
|
| Plasmodium | 1 | 2016 | 250 | 0.120 |
Why?
|
| Imipenem | 2 | 1991 | 37 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2009 | 3349 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 13 | 2005 | 1885 | 0.110 |
Why?
|
| Herpesvirus 2, Human | 1 | 1995 | 190 | 0.110 |
Why?
|
| Physicians | 4 | 2005 | 4625 | 0.110 |
Why?
|
| Communicable Diseases | 3 | 2005 | 892 | 0.110 |
Why?
|
| Child Health Services | 3 | 2016 | 668 | 0.110 |
Why?
|
| Health Services Misuse | 1 | 2015 | 243 | 0.110 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 2 | 2004 | 93 | 0.110 |
Why?
|
| Colony Count, Microbial | 5 | 2015 | 333 | 0.110 |
Why?
|
| Central Supply, Hospital | 1 | 1992 | 2 | 0.110 |
Why?
|
| Critical Pathways | 2 | 2013 | 482 | 0.110 |
Why?
|
| Nurseries, Hospital | 3 | 1989 | 16 | 0.110 |
Why?
|
| Neonatology | 1 | 2015 | 126 | 0.110 |
Why?
|
| Cohort Studies | 20 | 2014 | 40939 | 0.110 |
Why?
|
| England | 2 | 2014 | 528 | 0.110 |
Why?
|
| Gentamicins | 4 | 2001 | 254 | 0.110 |
Why?
|
| Penicillin G | 2 | 2001 | 42 | 0.110 |
Why?
|
| Nursing Staff, Hospital | 3 | 1992 | 345 | 0.110 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2015 | 351 | 0.110 |
Why?
|
| Lung Diseases | 4 | 2009 | 1890 | 0.110 |
Why?
|
| Azlocillin | 5 | 1999 | 19 | 0.110 |
Why?
|
| Medical Order Entry Systems | 2 | 2008 | 547 | 0.110 |
Why?
|
| Klebsiella pneumoniae | 2 | 2012 | 251 | 0.110 |
Why?
|
| Gels | 2 | 2005 | 425 | 0.110 |
Why?
|
| Injections, Intravenous | 4 | 2012 | 1420 | 0.110 |
Why?
|
| Time Factors | 19 | 2015 | 40195 | 0.110 |
Why?
|
| Drug Resistance | 2 | 2011 | 1603 | 0.100 |
Why?
|
| Health Care Costs | 4 | 2013 | 3217 | 0.100 |
Why?
|
| Utilization Review | 2 | 2009 | 392 | 0.100 |
Why?
|
| Interdepartmental Relations | 3 | 1997 | 13 | 0.100 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 609 | 0.100 |
Why?
|
| Bacteria | 7 | 2009 | 2145 | 0.100 |
Why?
|
| Georgia | 1 | 2011 | 187 | 0.100 |
Why?
|
| Patient Admission | 3 | 2003 | 1390 | 0.100 |
Why?
|
| Hygiene | 3 | 2019 | 97 | 0.100 |
Why?
|
| Catheterization, Peripheral | 1 | 1995 | 347 | 0.100 |
Why?
|
| Herpes Simplex | 1 | 1995 | 473 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2007 | 3561 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2022 | 1889 | 0.100 |
Why?
|
| Respiratory Function Tests | 7 | 2008 | 1631 | 0.100 |
Why?
|
| Patient-Centered Care | 3 | 2013 | 1445 | 0.100 |
Why?
|
| Epidemiology | 2 | 1991 | 287 | 0.100 |
Why?
|
| Craniocerebral Trauma | 2 | 2009 | 492 | 0.100 |
Why?
|
| Patient Satisfaction | 4 | 2013 | 3433 | 0.100 |
Why?
|
| Herpesvirus 3, Human | 1 | 1992 | 208 | 0.100 |
Why?
|
| Enterobacteriaceae Infections | 3 | 1984 | 190 | 0.100 |
Why?
|
| Boston | 12 | 2022 | 9348 | 0.100 |
Why?
|
| Critical Care | 2 | 2019 | 2696 | 0.100 |
Why?
|
| Rifampin | 5 | 1983 | 323 | 0.100 |
Why?
|
| Interviews as Topic | 2 | 2018 | 2580 | 0.100 |
Why?
|
| Hospitalization | 6 | 2023 | 10422 | 0.100 |
Why?
|
| Iatrogenic Disease | 2 | 2005 | 546 | 0.100 |
Why?
|
| Protective Clothing | 1 | 1991 | 102 | 0.100 |
Why?
|
| Cephalosporins | 2 | 2001 | 202 | 0.090 |
Why?
|
| Virulence | 6 | 2005 | 1328 | 0.090 |
Why?
|
| American Recovery and Reinvestment Act | 1 | 2011 | 71 | 0.090 |
Why?
|
| Pneumococcal Vaccines | 2 | 2005 | 393 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 4420 | 0.090 |
Why?
|
| Politics | 1 | 2017 | 798 | 0.090 |
Why?
|
| Nucleic Acid Probes | 1 | 1990 | 9 | 0.090 |
Why?
|
| Infusions, Parenteral | 3 | 1981 | 419 | 0.090 |
Why?
|
| Campylobacter | 1 | 1990 | 59 | 0.090 |
Why?
|
| Infant, Premature | 4 | 2010 | 2060 | 0.090 |
Why?
|
| Incidence | 11 | 2015 | 21146 | 0.090 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2018 | 1498 | 0.090 |
Why?
|
| Streptococcus pneumoniae | 3 | 2005 | 717 | 0.090 |
Why?
|
| Cephalothin | 2 | 2001 | 36 | 0.090 |
Why?
|
| Retrospective Studies | 17 | 2022 | 78758 | 0.090 |
Why?
|
| Adult | 36 | 2019 | 216658 | 0.090 |
Why?
|
| Information Dissemination | 2 | 2016 | 1107 | 0.090 |
Why?
|
| Illness Behavior | 1 | 2009 | 22 | 0.090 |
Why?
|
| Emergency Medical Services | 2 | 2014 | 1950 | 0.090 |
Why?
|
| Organizational Policy | 1 | 2012 | 427 | 0.090 |
Why?
|
| Rabbits | 11 | 2005 | 4910 | 0.090 |
Why?
|
| Membrane Proteins | 3 | 2002 | 7941 | 0.080 |
Why?
|
| Whooping Cough | 1 | 2010 | 83 | 0.080 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 2002 | 143 | 0.080 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2012 | 786 | 0.080 |
Why?
|
| Ventilators, Mechanical | 1 | 2011 | 294 | 0.080 |
Why?
|
| Electronic Health Records | 3 | 2019 | 4579 | 0.080 |
Why?
|
| Aerobiosis | 1 | 2008 | 106 | 0.080 |
Why?
|
| Anaerobiosis | 1 | 2008 | 140 | 0.080 |
Why?
|
| Disease Notification | 1 | 2009 | 98 | 0.080 |
Why?
|
| Sensitivity and Specificity | 6 | 2022 | 14761 | 0.080 |
Why?
|
| Immunization, Passive | 4 | 2005 | 621 | 0.080 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2007 | 647 | 0.080 |
Why?
|
| Coronary Artery Bypass | 2 | 2018 | 2275 | 0.080 |
Why?
|
| Iodophors | 1 | 1988 | 7 | 0.080 |
Why?
|
| Interprofessional Relations | 2 | 2015 | 1019 | 0.080 |
Why?
|
| Infusions, Intravenous | 1 | 1993 | 2289 | 0.080 |
Why?
|
| Pharynx | 4 | 1988 | 423 | 0.080 |
Why?
|
| Statistics, Nonparametric | 3 | 2009 | 2888 | 0.080 |
Why?
|
| Quality Control | 2 | 2006 | 839 | 0.080 |
Why?
|
| Decision Support Techniques | 2 | 2010 | 1984 | 0.080 |
Why?
|
| Time | 1 | 2009 | 548 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2018 | 1486 | 0.070 |
Why?
|
| Neuromuscular Diseases | 1 | 2010 | 252 | 0.070 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 1101 | 0.070 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2000 | 408 | 0.070 |
Why?
|
| Feasibility Studies | 3 | 2012 | 5144 | 0.070 |
Why?
|
| Fat Emulsions, Intravenous | 3 | 1998 | 323 | 0.070 |
Why?
|
| Patient Education as Topic | 4 | 2019 | 2297 | 0.070 |
Why?
|
| Patient Care Management | 1 | 2010 | 308 | 0.070 |
Why?
|
| Odds Ratio | 6 | 2016 | 9863 | 0.070 |
Why?
|
| Animals, Newborn | 5 | 2015 | 2730 | 0.070 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 4 | 2005 | 60 | 0.070 |
Why?
|
| Focus Groups | 1 | 2011 | 1348 | 0.070 |
Why?
|
| Chronic Disease | 3 | 2009 | 9223 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 3 | 1992 | 1798 | 0.070 |
Why?
|
| Malaria | 1 | 2016 | 1243 | 0.070 |
Why?
|
| DNA, Bacterial | 4 | 2004 | 1467 | 0.070 |
Why?
|
| Streptococcus | 2 | 2002 | 197 | 0.070 |
Why?
|
| Patient Participation | 1 | 2016 | 1464 | 0.070 |
Why?
|
| Follow-Up Studies | 9 | 2019 | 39223 | 0.070 |
Why?
|
| Penicillin Resistance | 6 | 2001 | 84 | 0.070 |
Why?
|
| Public Policy | 1 | 2011 | 577 | 0.070 |
Why?
|
| Public Health Informatics | 2 | 2005 | 111 | 0.070 |
Why?
|
| Amidohydrolases | 1 | 2007 | 170 | 0.070 |
Why?
|
| Ampicillin | 4 | 2001 | 140 | 0.070 |
Why?
|
| Air Microbiology | 2 | 1992 | 87 | 0.070 |
Why?
|
| Streptococcus agalactiae | 3 | 1988 | 376 | 0.070 |
Why?
|
| Acute Disease | 4 | 2023 | 7221 | 0.070 |
Why?
|
| Biofilms | 3 | 2007 | 622 | 0.070 |
Why?
|
| Pseudomonas | 1 | 1986 | 119 | 0.070 |
Why?
|
| Thienamycins | 1 | 1985 | 27 | 0.070 |
Why?
|
| Child, Hospitalized | 1 | 2007 | 178 | 0.070 |
Why?
|
| Job Satisfaction | 1 | 2009 | 538 | 0.070 |
Why?
|
| Insurance, Health | 4 | 2016 | 2501 | 0.070 |
Why?
|
| Fatal Outcome | 2 | 2004 | 1859 | 0.070 |
Why?
|
| Data Mining | 1 | 2011 | 543 | 0.070 |
Why?
|
| Capnography | 1 | 2006 | 91 | 0.070 |
Why?
|
| Patient Identification Systems | 1 | 2006 | 79 | 0.070 |
Why?
|
| Nasopharynx | 2 | 2005 | 394 | 0.070 |
Why?
|
| Antibody Specificity | 2 | 2005 | 1089 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 944 | 0.060 |
Why?
|
| Mandatory Reporting | 1 | 2006 | 124 | 0.060 |
Why?
|
| Defensins | 2 | 2002 | 35 | 0.060 |
Why?
|
| Feces | 2 | 1990 | 1419 | 0.060 |
Why?
|
| Iodine | 1 | 1988 | 289 | 0.060 |
Why?
|
| Information Services | 1 | 2006 | 241 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 4 | 2006 | 1203 | 0.060 |
Why?
|
| Clinical Pharmacy Information Systems | 2 | 2003 | 103 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 1992 | 2227 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10914 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 3500 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2012 | 1547 | 0.060 |
Why?
|
| Respiration, Artificial | 2 | 2016 | 2611 | 0.060 |
Why?
|
| Mannose | 1 | 1985 | 125 | 0.060 |
Why?
|
| Respiratory Syncytial Viruses | 3 | 1992 | 169 | 0.060 |
Why?
|
| Social Support | 1 | 2014 | 2145 | 0.060 |
Why?
|
| Perception | 1 | 2011 | 1199 | 0.060 |
Why?
|
| Students | 1 | 2014 | 1668 | 0.060 |
Why?
|
| Teicoplanin | 1 | 2004 | 26 | 0.060 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2008 | 497 | 0.060 |
Why?
|
| Microbiological Techniques | 1 | 2005 | 101 | 0.060 |
Why?
|
| Professional-Patient Relations | 1 | 2009 | 739 | 0.060 |
Why?
|
| Video Games | 1 | 2006 | 185 | 0.060 |
Why?
|
| Emergency Treatment | 1 | 2008 | 520 | 0.060 |
Why?
|
| Survival Rate | 3 | 2009 | 12802 | 0.060 |
Why?
|
| Nervous System Diseases | 3 | 2016 | 1636 | 0.060 |
Why?
|
| Antimicrobial Cationic Peptides | 3 | 2002 | 365 | 0.060 |
Why?
|
| Age Distribution | 1 | 2010 | 2905 | 0.060 |
Why?
|
| Nurses | 3 | 2005 | 2476 | 0.060 |
Why?
|
| Nursing Care | 1 | 2004 | 74 | 0.060 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2007 | 491 | 0.060 |
Why?
|
| Medical Informatics | 1 | 2011 | 748 | 0.060 |
Why?
|
| Cyclopropanes | 1 | 1985 | 414 | 0.060 |
Why?
|
| Patient Care | 1 | 2009 | 638 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2005 | 623 | 0.060 |
Why?
|
| Television | 1 | 2006 | 406 | 0.060 |
Why?
|
| Blood Specimen Collection | 2 | 2003 | 245 | 0.060 |
Why?
|
| Family Practice | 2 | 2005 | 517 | 0.060 |
Why?
|
| Infant Care | 1 | 2005 | 178 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 980 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2611 | 0.060 |
Why?
|
| Social Responsibility | 1 | 2006 | 391 | 0.060 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 25454 | 0.060 |
Why?
|
| Infant, Premature, Diseases | 1 | 2009 | 704 | 0.060 |
Why?
|
| Hospital Communication Systems | 1 | 2003 | 51 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2015 | 2033 | 0.050 |
Why?
|
| Qualitative Research | 3 | 2024 | 2778 | 0.050 |
Why?
|
| Cephamycins | 1 | 1982 | 7 | 0.050 |
Why?
|
| Drug Therapy | 2 | 2004 | 501 | 0.050 |
Why?
|
| Gastroenteritis | 3 | 1997 | 245 | 0.050 |
Why?
|
| Immunization | 3 | 1993 | 1254 | 0.050 |
Why?
|
| Bacterial Vaccines | 2 | 2000 | 406 | 0.050 |
Why?
|
| Pneumococcal Infections | 2 | 2005 | 502 | 0.050 |
Why?
|
| Immunity, Innate | 2 | 2012 | 3002 | 0.050 |
Why?
|
| Cesarean Section | 2 | 2001 | 1428 | 0.050 |
Why?
|
| Gram-Positive Cocci | 1 | 2001 | 9 | 0.050 |
Why?
|
| Epitopes | 2 | 2006 | 2584 | 0.050 |
Why?
|
| Decision Making | 3 | 2005 | 3909 | 0.050 |
Why?
|
| Risk Adjustment | 2 | 2010 | 598 | 0.050 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2003 | 565 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1999 | 3885 | 0.050 |
Why?
|
| Animals | 27 | 2015 | 169600 | 0.050 |
Why?
|
| Age Factors | 8 | 2010 | 18460 | 0.050 |
Why?
|
| HIV | 1 | 1989 | 1610 | 0.050 |
Why?
|
| Professional Autonomy | 1 | 2003 | 177 | 0.050 |
Why?
|
| Drug Interactions | 3 | 2005 | 1447 | 0.050 |
Why?
|
| Analysis of Variance | 7 | 2005 | 6352 | 0.050 |
Why?
|
| Primary Health Care | 2 | 2017 | 4624 | 0.050 |
Why?
|
| Steel | 1 | 1981 | 26 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 1984 | 435 | 0.050 |
Why?
|
| Parent-Child Relations | 1 | 2006 | 747 | 0.050 |
Why?
|
| Culture | 1 | 2005 | 636 | 0.050 |
Why?
|
| User-Computer Interface | 2 | 2005 | 1432 | 0.050 |
Why?
|
| Publishing | 1 | 2008 | 840 | 0.050 |
Why?
|
| Young Adult | 6 | 2023 | 57267 | 0.050 |
Why?
|
| Organizational Objectives | 1 | 2003 | 438 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2005 | 8413 | 0.050 |
Why?
|
| Polysaccharides | 2 | 1985 | 1050 | 0.050 |
Why?
|
| Dithioerythritol | 1 | 1980 | 8 | 0.050 |
Why?
|
| Child Behavior | 1 | 2006 | 836 | 0.050 |
Why?
|
| Alloys | 1 | 1981 | 123 | 0.050 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2011 | 1209 | 0.050 |
Why?
|
| Clinical Protocols | 3 | 2002 | 1463 | 0.050 |
Why?
|
| Latex Fixation Tests | 3 | 1992 | 32 | 0.050 |
Why?
|
| Dithiothreitol | 1 | 1980 | 100 | 0.050 |
Why?
|
| Medicaid | 6 | 2018 | 2776 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2005 | 645 | 0.050 |
Why?
|
| Health Facility Merger | 1 | 2001 | 53 | 0.050 |
Why?
|
| Comorbidity | 2 | 2019 | 10450 | 0.050 |
Why?
|
| Linear Models | 4 | 2013 | 5965 | 0.050 |
Why?
|
| Fluid Therapy | 1 | 1984 | 590 | 0.050 |
Why?
|
| Family Health | 1 | 2005 | 1279 | 0.050 |
Why?
|
| Polytetrafluoroethylene | 1 | 1981 | 235 | 0.040 |
Why?
|
| Heart Valve Prosthesis | 3 | 1999 | 1494 | 0.040 |
Why?
|
| North Carolina | 2 | 2010 | 317 | 0.040 |
Why?
|
| DNA Transposable Elements | 2 | 1994 | 749 | 0.040 |
Why?
|
| Clinical Competence | 3 | 2009 | 4729 | 0.040 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2009 | 1185 | 0.040 |
Why?
|
| Prevalence | 3 | 2023 | 15404 | 0.040 |
Why?
|
| Research Design | 2 | 2011 | 6118 | 0.040 |
Why?
|
| Eating | 1 | 2006 | 1563 | 0.040 |
Why?
|
| Continuity of Patient Care | 3 | 2013 | 1056 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 2446 | 0.040 |
Why?
|
| Drug Therapy, Combination | 5 | 1999 | 6493 | 0.040 |
Why?
|
| Orthomyxoviridae | 1 | 2001 | 155 | 0.040 |
Why?
|
| Aerosols | 2 | 2000 | 627 | 0.040 |
Why?
|
| Cost of Illness | 2 | 2008 | 1873 | 0.040 |
Why?
|
| Bandages | 1 | 2001 | 267 | 0.040 |
Why?
|
| Clinical Trials as Topic | 6 | 2005 | 7970 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 3120 | 0.040 |
Why?
|
| Chickenpox | 1 | 1980 | 131 | 0.040 |
Why?
|
| Random Allocation | 4 | 1988 | 2426 | 0.040 |
Why?
|
| Arthritis, Infectious | 1 | 2003 | 369 | 0.040 |
Why?
|
| Bronchiolitis | 1 | 2005 | 463 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 1999 | 191 | 0.040 |
Why?
|
| Reproducibility of Results | 5 | 2014 | 20026 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4316 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 2 | 2024 | 936 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 3 | 2013 | 5410 | 0.040 |
Why?
|
| Prognosis | 4 | 2014 | 29264 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 2761 | 0.040 |
Why?
|
| Uncertainty | 1 | 2004 | 744 | 0.040 |
Why?
|
| Parenteral Nutrition | 2 | 1974 | 655 | 0.040 |
Why?
|
| Economic Competition | 1 | 2001 | 216 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2023 | 611 | 0.040 |
Why?
|
| beta-Lactamases | 2 | 1991 | 307 | 0.040 |
Why?
|
| Salmonella Infections | 1 | 1980 | 172 | 0.040 |
Why?
|
| Neutrophils | 2 | 2002 | 3729 | 0.040 |
Why?
|
| Communication | 3 | 2015 | 3815 | 0.040 |
Why?
|
| Mycoses | 2 | 1989 | 389 | 0.040 |
Why?
|
| Sisomicin | 1 | 1977 | 6 | 0.040 |
Why?
|
| Sterilization | 4 | 1992 | 134 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2004 | 1124 | 0.040 |
Why?
|
| Needles | 1 | 1981 | 451 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 1982 | 1664 | 0.040 |
Why?
|
| Middle Aged | 15 | 2019 | 216054 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2002 | 1262 | 0.040 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 1998 | 169 | 0.040 |
Why?
|
| Disclosure | 1 | 2003 | 744 | 0.040 |
Why?
|
| Administration, Intranasal | 1 | 2019 | 476 | 0.040 |
Why?
|
| Health Occupations | 2 | 1989 | 224 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 3 | 2010 | 9300 | 0.040 |
Why?
|
| Fever | 3 | 2000 | 1627 | 0.030 |
Why?
|
| Evidence-Based Medicine | 3 | 2003 | 3652 | 0.030 |
Why?
|
| Hip Joint | 1 | 2003 | 1021 | 0.030 |
Why?
|
| Endophthalmitis | 1 | 1999 | 263 | 0.030 |
Why?
|
| Mothers | 2 | 2005 | 2190 | 0.030 |
Why?
|
| HIV Infections | 1 | 2002 | 16882 | 0.030 |
Why?
|
| Philippines | 2 | 2009 | 87 | 0.030 |
Why?
|
| Internet | 2 | 2006 | 3074 | 0.030 |
Why?
|
| Mice | 12 | 2015 | 81766 | 0.030 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 1998 | 253 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2015 | 55 | 0.030 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1995 | 95 | 0.030 |
Why?
|
| Heart Valves | 1 | 1977 | 290 | 0.030 |
Why?
|
| Chemokine CXCL1 | 1 | 2015 | 100 | 0.030 |
Why?
|
| Cross Reactions | 2 | 1989 | 842 | 0.030 |
Why?
|
| Health Facilities | 1 | 2020 | 588 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2007 | 1890 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2012 | 15459 | 0.030 |
Why?
|
| Robotics | 1 | 2002 | 890 | 0.030 |
Why?
|
| Bacterial Proteins | 2 | 2005 | 3860 | 0.030 |
Why?
|
| Predictive Value of Tests | 4 | 2008 | 15164 | 0.030 |
Why?
|
| State Government | 1 | 2017 | 373 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 2491 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 4943 | 0.030 |
Why?
|
| Russia | 2 | 2007 | 408 | 0.030 |
Why?
|
| Teichoic Acids | 4 | 2000 | 65 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 2739 | 0.030 |
Why?
|
| Israel | 1 | 2016 | 807 | 0.030 |
Why?
|
| Health Status | 1 | 2007 | 4077 | 0.030 |
Why?
|
| Inpatients | 2 | 2007 | 2549 | 0.030 |
Why?
|
| Developed Countries | 1 | 1997 | 442 | 0.030 |
Why?
|
| Vaccines, Conjugate | 2 | 2005 | 334 | 0.030 |
Why?
|
| Pain | 1 | 2009 | 5040 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 263 | 0.030 |
Why?
|
| Registries | 1 | 2010 | 8216 | 0.030 |
Why?
|
| Oropharynx | 3 | 1983 | 127 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2015 | 3198 | 0.030 |
Why?
|
| Management Quality Circles | 1 | 1993 | 21 | 0.030 |
Why?
|
| Health Priorities | 1 | 1997 | 381 | 0.030 |
Why?
|
| Trimethoprim | 2 | 1983 | 91 | 0.030 |
Why?
|
| Plasmids | 4 | 1993 | 2316 | 0.030 |
Why?
|
| Administrative Personnel | 1 | 2015 | 189 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 6624 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 4638 | 0.030 |
Why?
|
| Hospitals, Urban | 2 | 2007 | 500 | 0.030 |
Why?
|
| Prejudice | 1 | 1997 | 571 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2018 | 767 | 0.030 |
Why?
|
| Spleen | 2 | 2015 | 2369 | 0.030 |
Why?
|
| Prospective Payment System | 1 | 2013 | 133 | 0.030 |
Why?
|
| Physician-Patient Relations | 3 | 2013 | 3254 | 0.030 |
Why?
|
| Time and Motion Studies | 1 | 1993 | 149 | 0.030 |
Why?
|
| Laboratories, Hospital | 2 | 1992 | 195 | 0.030 |
Why?
|
| Genes, Bacterial | 3 | 2004 | 1081 | 0.030 |
Why?
|
| Osteitis Deformans | 1 | 1992 | 54 | 0.030 |
Why?
|
| Patient Selection | 1 | 2005 | 4232 | 0.030 |
Why?
|
| Prosthesis-Related Infections | 1 | 1999 | 553 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2015 | 750 | 0.030 |
Why?
|
| Back Pain | 1 | 2016 | 546 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 616 | 0.030 |
Why?
|
| Faculty, Medical | 2 | 2009 | 1187 | 0.030 |
Why?
|
| Joint Diseases | 1 | 2016 | 484 | 0.030 |
Why?
|
| Disease Models, Animal | 5 | 2015 | 18174 | 0.030 |
Why?
|
| Judgment | 1 | 1994 | 280 | 0.030 |
Why?
|
| Goals | 1 | 2017 | 716 | 0.030 |
Why?
|
| Risk Assessment | 6 | 2013 | 23554 | 0.030 |
Why?
|
| Poverty | 3 | 2001 | 2682 | 0.030 |
Why?
|
| Immune Sera | 2 | 1999 | 642 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2005 | 13042 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1991 | 1371 | 0.030 |
Why?
|
| Advisory Committees | 1 | 2016 | 779 | 0.030 |
Why?
|
| Surgical Attire | 1 | 2011 | 5 | 0.020 |
Why?
|
| Forecasting | 1 | 2001 | 2956 | 0.020 |
Why?
|
| Medication Systems, Hospital | 2 | 2003 | 157 | 0.020 |
Why?
|
| Spinal Dysraphism | 1 | 1993 | 163 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1983 | 2182 | 0.020 |
Why?
|
| Referral and Consultation | 3 | 2013 | 3573 | 0.020 |
Why?
|
| Gloves, Protective | 1 | 2011 | 22 | 0.020 |
Why?
|
| Rotavirus Infections | 1 | 1992 | 86 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 3069 | 0.020 |
Why?
|
| Logistic Models | 3 | 1997 | 13441 | 0.020 |
Why?
|
| Stroke | 1 | 2014 | 10152 | 0.020 |
Why?
|
| Environmental Exposure | 2 | 2000 | 4344 | 0.020 |
Why?
|
| Motivation | 1 | 2021 | 1990 | 0.020 |
Why?
|
| Fiber Optic Technology | 1 | 1992 | 292 | 0.020 |
Why?
|
| Policy Making | 1 | 2015 | 552 | 0.020 |
Why?
|
| Forms and Records Control | 2 | 2005 | 159 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1993 | 20346 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1992 | 225 | 0.020 |
Why?
|
| Liver | 3 | 2015 | 7538 | 0.020 |
Why?
|
| Treatment Outcome | 7 | 2014 | 64017 | 0.020 |
Why?
|
| Asepsis | 1 | 1990 | 5 | 0.020 |
Why?
|
| Campylobacter Infections | 1 | 1990 | 32 | 0.020 |
Why?
|
| Chloramphenicol | 2 | 1981 | 74 | 0.020 |
Why?
|
| Problem Solving | 1 | 1993 | 440 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2015 | 697 | 0.020 |
Why?
|
| Staff Development | 1 | 1992 | 225 | 0.020 |
Why?
|
| Occupational Diseases | 1 | 1998 | 1471 | 0.020 |
Why?
|
| Cell Separation | 2 | 1999 | 1751 | 0.020 |
Why?
|
| False Positive Reactions | 2 | 1991 | 965 | 0.020 |
Why?
|
| Endocarditis | 1 | 1994 | 357 | 0.020 |
Why?
|
| Double-Blind Method | 5 | 2006 | 12202 | 0.020 |
Why?
|
| Animals, Suckling | 1 | 1989 | 72 | 0.020 |
Why?
|
| Aged | 8 | 2019 | 165629 | 0.020 |
Why?
|
| Weight Loss | 1 | 2021 | 2679 | 0.020 |
Why?
|
| Radiology Department, Hospital | 1 | 1993 | 413 | 0.020 |
Why?
|
| Fatigue | 1 | 2016 | 1536 | 0.020 |
Why?
|
| Life Style | 1 | 2021 | 3861 | 0.020 |
Why?
|
| Surgery Department, Hospital | 1 | 1990 | 180 | 0.020 |
Why?
|
| Monitoring, Physiologic | 2 | 2006 | 1750 | 0.020 |
Why?
|
| Heart Failure | 1 | 2013 | 11096 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2000 | 1515 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 555 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 602 | 0.020 |
Why?
|
| Universities | 1 | 2014 | 970 | 0.020 |
Why?
|
| Accreditation | 1 | 1992 | 467 | 0.020 |
Why?
|
| Workflow | 1 | 2013 | 852 | 0.020 |
Why?
|
| Risk | 5 | 1998 | 9683 | 0.020 |
Why?
|
| Kinetics | 4 | 1985 | 6482 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2007 | 2746 | 0.020 |
Why?
|
| Environmental Microbiology | 1 | 1988 | 46 | 0.020 |
Why?
|
| Government Agencies | 1 | 1988 | 161 | 0.020 |
Why?
|
| Reference Values | 2 | 2008 | 4994 | 0.020 |
Why?
|
| Blood Cells | 1 | 1990 | 310 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2021 | 12821 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 1992 | 606 | 0.020 |
Why?
|
| Methods | 2 | 1981 | 1132 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2012 | 1998 | 0.020 |
Why?
|
| Species Specificity | 2 | 1984 | 2483 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1993 | 1614 | 0.020 |
Why?
|
| Leadership | 1 | 1997 | 1378 | 0.020 |
Why?
|
| Latin America | 1 | 1988 | 384 | 0.020 |
Why?
|
| Child Welfare | 1 | 2011 | 521 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2004 | 21904 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2009 | 361 | 0.020 |
Why?
|
| Meningomyelocele | 1 | 1988 | 165 | 0.020 |
Why?
|
| Medical Records | 2 | 2006 | 1412 | 0.020 |
Why?
|
| Klebsiella | 2 | 1978 | 47 | 0.020 |
Why?
|
| Milk | 1 | 1989 | 450 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 1992 | 671 | 0.020 |
Why?
|
| ROC Curve | 2 | 2010 | 3558 | 0.020 |
Why?
|
| Triage | 1 | 1993 | 985 | 0.020 |
Why?
|
| Cilastatin | 1 | 1985 | 11 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 12423 | 0.020 |
Why?
|
| Vaccination | 3 | 2006 | 3354 | 0.020 |
Why?
|
| Decision Trees | 1 | 1987 | 506 | 0.020 |
Why?
|
| Immunoglobulin G | 3 | 2005 | 4575 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4194 | 0.020 |
Why?
|
| Plankton | 1 | 2005 | 21 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 22009 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 6169 | 0.020 |
Why?
|
| Agglutination Tests | 1 | 1985 | 40 | 0.020 |
Why?
|
| Chemical Precipitation | 1 | 1985 | 179 | 0.020 |
Why?
|
| Socioeconomic Factors | 4 | 2006 | 7852 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2008 | 439 | 0.020 |
Why?
|
| Serotyping | 1 | 2005 | 336 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2000 | 5107 | 0.020 |
Why?
|
| Financing, Government | 1 | 1988 | 466 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 7708 | 0.020 |
Why?
|
| Rats | 3 | 1989 | 24248 | 0.020 |
Why?
|
| Sex Factors | 3 | 2008 | 10469 | 0.020 |
Why?
|
| Empyema | 1 | 1984 | 41 | 0.020 |
Why?
|
| Physicians, Primary Care | 1 | 2011 | 605 | 0.020 |
Why?
|
| Pneumonia | 4 | 1991 | 2154 | 0.020 |
Why?
|
| Palliative Care | 1 | 1999 | 3546 | 0.020 |
Why?
|
| DNA Topoisomerase IV | 1 | 2004 | 40 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2005 | 211 | 0.010 |
Why?
|
| Teaching | 1 | 1992 | 1176 | 0.010 |
Why?
|
| Observer Variation | 1 | 2010 | 2622 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 12165 | 0.010 |
Why?
|
| Obesity | 1 | 2006 | 12868 | 0.010 |
Why?
|
| Complement C3 | 1 | 2006 | 463 | 0.010 |
Why?
|
| Meningitis, Haemophilus | 2 | 1981 | 21 | 0.010 |
Why?
|
| Greece | 1 | 1984 | 347 | 0.010 |
Why?
|
| Adhesiveness | 1 | 1983 | 53 | 0.010 |
Why?
|
| Restaurants | 1 | 2006 | 234 | 0.010 |
Why?
|
| Serratia marcescens | 2 | 1990 | 45 | 0.010 |
Why?
|
| Schools | 1 | 1992 | 1443 | 0.010 |
Why?
|
| Phagocytes | 1 | 2005 | 297 | 0.010 |
Why?
|
| Oxacillin | 1 | 1983 | 42 | 0.010 |
Why?
|
| Attitude to Computers | 1 | 2004 | 202 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1988 | 520 | 0.010 |
Why?
|
| Health Surveys | 2 | 2006 | 4050 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2015 | 3802 | 0.010 |
Why?
|
| Genes, Regulator | 1 | 2004 | 378 | 0.010 |
Why?
|
| Solubility | 1 | 1985 | 1091 | 0.010 |
Why?
|
| North America | 1 | 2006 | 1255 | 0.010 |
Why?
|
| Moxalactam | 1 | 1982 | 10 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 1991 | 1732 | 0.010 |
Why?
|
| Immunochemistry | 1 | 2002 | 124 | 0.010 |
Why?
|
| Computer Systems | 1 | 2004 | 481 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 7805 | 0.010 |
Why?
|
| Acetylation | 1 | 2005 | 1074 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1985 | 2260 | 0.010 |
Why?
|
| Patient Access to Records | 1 | 2003 | 119 | 0.010 |
Why?
|
| Weight Gain | 1 | 2012 | 2317 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 1990 | 1390 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1984 | 398 | 0.010 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2003 | 133 | 0.010 |
Why?
|
| Cell Extracts | 1 | 2002 | 138 | 0.010 |
Why?
|
| Endometritis | 1 | 2001 | 49 | 0.010 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2001 | 43 | 0.010 |
Why?
|
| Glucuronates | 1 | 1981 | 40 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58361 | 0.010 |
Why?
|
| Hospitals, Voluntary | 1 | 2001 | 40 | 0.010 |
Why?
|
| Sentinel Surveillance | 1 | 2003 | 281 | 0.010 |
Why?
|
| Myanmar | 1 | 2001 | 44 | 0.010 |
Why?
|
| Thiamphenicol | 1 | 1981 | 2 | 0.010 |
Why?
|
| Electronic Mail | 1 | 2003 | 212 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2007 | 1687 | 0.010 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2003 | 204 | 0.010 |
Why?
|
| Digestive System | 1 | 1982 | 254 | 0.010 |
Why?
|
| Equipment Design | 1 | 1990 | 3589 | 0.010 |
Why?
|
| Phlebitis | 1 | 1981 | 31 | 0.010 |
Why?
|
| Milk, Human | 1 | 2006 | 483 | 0.010 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1983 | 211 | 0.010 |
Why?
|
| Algorithms | 2 | 2004 | 13984 | 0.010 |
Why?
|
| Colombia | 1 | 2001 | 260 | 0.010 |
Why?
|
| Fruit | 1 | 2006 | 1151 | 0.010 |
Why?
|
| Ileum | 1 | 1983 | 563 | 0.010 |
Why?
|
| Vegetables | 1 | 2006 | 1186 | 0.010 |
Why?
|
| Brain | 1 | 1988 | 26598 | 0.010 |
Why?
|
| Pregnancy | 5 | 2001 | 29630 | 0.010 |
Why?
|
| Mouth | 1 | 1983 | 378 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2006 | 2978 | 0.010 |
Why?
|
| Vagina | 1 | 1986 | 830 | 0.010 |
Why?
|
| Medically Uninsured | 2 | 1997 | 858 | 0.010 |
Why?
|
| Biological Transport | 1 | 2005 | 2121 | 0.010 |
Why?
|
| Thailand | 1 | 2001 | 296 | 0.010 |
Why?
|
| Air Movements | 1 | 1980 | 42 | 0.010 |
Why?
|
| Communication Barriers | 1 | 2003 | 407 | 0.010 |
Why?
|
| Hungary | 1 | 2000 | 84 | 0.010 |
Why?
|
| Body Height | 1 | 2006 | 1586 | 0.010 |
Why?
|
| Telephone | 1 | 2003 | 624 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1985 | 2559 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14596 | 0.010 |
Why?
|
| Philadelphia | 1 | 2000 | 271 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2002 | 508 | 0.010 |
Why?
|
| Epithelium | 1 | 1984 | 1682 | 0.010 |
Why?
|
| Salmonella | 1 | 1980 | 129 | 0.010 |
Why?
|
| Skin | 1 | 1993 | 4393 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2001 | 691 | 0.010 |
Why?
|
| Germany | 1 | 2001 | 873 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 1972 | 0.010 |
Why?
|
| Cellulitis | 1 | 1981 | 210 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2001 | 712 | 0.010 |
Why?
|
| Citrobacter | 1 | 1978 | 4 | 0.010 |
Why?
|
| Hospital Units | 1 | 1980 | 141 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 3966 | 0.010 |
Why?
|
| Enterobacter | 1 | 1978 | 46 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1988 | 2258 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1998 | 320 | 0.010 |
Why?
|
| Amino Acids | 1 | 1985 | 1744 | 0.010 |
Why?
|
| Umbilicus | 1 | 1978 | 41 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 1980 | 351 | 0.010 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2003 | 784 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1987 | 2729 | 0.010 |
Why?
|
| Hepatitis B virus | 1 | 1981 | 524 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 13011 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 1919 | 0.010 |
Why?
|
| Candida albicans | 1 | 1980 | 396 | 0.010 |
Why?
|
| Enterobacteriaceae | 2 | 1981 | 171 | 0.010 |
Why?
|
| Physicians' Offices | 2 | 1988 | 58 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1989 | 3012 | 0.010 |
Why?
|
| Antigens | 1 | 1982 | 1466 | 0.010 |
Why?
|
| Leukocytosis | 1 | 1978 | 246 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1983 | 2376 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1999 | 932 | 0.010 |
Why?
|
| Curriculum | 1 | 2009 | 3633 | 0.010 |
Why?
|
| Adolescent, Hospitalized | 1 | 1995 | 31 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 4703 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2002 | 1221 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1998 | 803 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2002 | 1059 | 0.010 |
Why?
|
| International Cooperation | 1 | 2001 | 1439 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 12769 | 0.010 |
Why?
|
| Cromolyn Sodium | 1 | 1995 | 87 | 0.010 |
Why?
|
| Nose | 1 | 1978 | 511 | 0.010 |
Why?
|
| India | 1 | 2001 | 2239 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 2003 | 1087 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 5974 | 0.010 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1995 | 139 | 0.010 |
Why?
|
| Kidney | 2 | 2000 | 7152 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 12054 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 2912 | 0.010 |
Why?
|
| Shigella | 1 | 1974 | 75 | 0.010 |
Why?
|
| Dysentery, Bacillary | 1 | 1974 | 75 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2001 | 1016 | 0.010 |
Why?
|
| Hypotonic Solutions | 1 | 1973 | 49 | 0.010 |
Why?
|
| Hexachlorophene | 1 | 1973 | 5 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1999 | 1610 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1995 | 345 | 0.010 |
Why?
|
| Periarthritis | 1 | 1992 | 4 | 0.010 |
Why?
|
| Public Health | 1 | 2006 | 2634 | 0.010 |
Why?
|
| Transformation, Bacterial | 1 | 1993 | 78 | 0.010 |
Why?
|
| Intestines | 1 | 1982 | 1924 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 18050 | 0.010 |
Why?
|
| Quality of Life | 1 | 2014 | 13044 | 0.010 |
Why?
|
| Orthopedic Procedures | 1 | 2003 | 1295 | 0.010 |
Why?
|
| Arthritis, Gouty | 1 | 1992 | 28 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1985 | 13778 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 5858 | 0.010 |
Why?
|
| Filtration | 1 | 1973 | 233 | 0.010 |
Why?
|
| Iowa | 1 | 1992 | 101 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1983 | 3062 | 0.010 |
Why?
|
| Candida | 1 | 1973 | 171 | 0.010 |
Why?
|
| Complement Activation | 1 | 1994 | 452 | 0.010 |
Why?
|
| Ulna | 1 | 1992 | 133 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 5149 | 0.010 |
Why?
|
| Maryland | 1 | 1992 | 272 | 0.010 |
Why?
|
| Indonesia | 1 | 1991 | 118 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1994 | 654 | 0.010 |
Why?
|
| Obstetrics | 1 | 1998 | 676 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 13364 | 0.010 |
Why?
|
| Prenatal Care | 1 | 1998 | 1106 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1991 | 214 | 0.010 |
Why?
|
| Hospital Bed Capacity | 1 | 1992 | 215 | 0.010 |
Why?
|
| Conjugation, Genetic | 1 | 1991 | 126 | 0.010 |
Why?
|
| Micrococcus | 1 | 1990 | 13 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2003 | 2322 | 0.010 |
Why?
|
| Software | 1 | 2004 | 4460 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1990 | 156 | 0.010 |
Why?
|
| Proteins | 2 | 1999 | 6093 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 1978 | 1077 | 0.010 |
Why?
|
| Steroids | 1 | 1995 | 940 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 1676 | 0.010 |
Why?
|
| Blood Preservation | 1 | 1990 | 176 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 23512 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1990 | 440 | 0.000 |
Why?
|
| Silicone Elastomers | 1 | 1988 | 83 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1984 | 19270 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1999 | 2136 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1988 | 218 | 0.000 |
Why?
|
| Phosphotransferases | 1 | 1988 | 309 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 4298 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9664 | 0.000 |
Why?
|
| Iothalamic Acid | 1 | 1985 | 18 | 0.000 |
Why?
|
| Albumins | 1 | 1988 | 564 | 0.000 |
Why?
|
| Educational Status | 1 | 1993 | 2573 | 0.000 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1995 | 1812 | 0.000 |
Why?
|
| Osteoarthritis | 1 | 1992 | 1049 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 2644 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1993 | 4723 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1988 | 1768 | 0.000 |
Why?
|
| Income | 1 | 1993 | 1921 | 0.000 |
Why?
|
| Lung | 1 | 1983 | 9990 | 0.000 |
Why?
|
| Glucose | 1 | 1995 | 4396 | 0.000 |
Why?
|
| Endoscopy | 1 | 1992 | 1839 | 0.000 |
Why?
|
| Radiography | 1 | 1992 | 7047 | 0.000 |
Why?
|
| Laryngitis | 1 | 1981 | 27 | 0.000 |
Why?
|
| Chewing Gum | 1 | 1981 | 41 | 0.000 |
Why?
|
| Hydrocephalus | 1 | 1988 | 761 | 0.000 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1981 | 222 | 0.000 |
Why?
|
| Epiglottis | 1 | 1981 | 81 | 0.000 |
Why?
|
| Hepatitis B Core Antigens | 1 | 1981 | 91 | 0.000 |
Why?
|
| Seizures | 1 | 1993 | 2887 | 0.000 |
Why?
|
| Creatinine | 1 | 1985 | 1893 | 0.000 |
Why?
|
| Acetyltransferases | 1 | 1981 | 233 | 0.000 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1981 | 307 | 0.000 |
Why?
|
| Histocompatibility Testing | 1 | 1981 | 726 | 0.000 |
Why?
|
| Lipids | 1 | 1990 | 3326 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1990 | 2526 | 0.000 |
Why?
|
| Drainage | 1 | 1984 | 1147 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1985 | 2160 | 0.000 |
Why?
|
| Thoracic Surgery | 1 | 1984 | 707 | 0.000 |
Why?
|
| Radiography, Thoracic | 1 | 1984 | 1279 | 0.000 |
Why?
|
| Syringes | 1 | 1976 | 55 | 0.000 |
Why?
|
| Edetic Acid | 1 | 1976 | 273 | 0.000 |
Why?
|
| Placebos | 1 | 1981 | 1675 | 0.000 |
Why?
|
| Phenotype | 1 | 1994 | 16484 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1990 | 6318 | 0.000 |
Why?
|
| Water Pollution | 1 | 1974 | 33 | 0.000 |
Why?
|
| Waste Disposal, Fluid | 1 | 1974 | 31 | 0.000 |
Why?
|
| Arizona | 1 | 1974 | 108 | 0.000 |
Why?
|
| Food Handling | 1 | 1974 | 147 | 0.000 |
Why?
|
| DNA | 1 | 1988 | 7312 | 0.000 |
Why?
|
| Water Microbiology | 1 | 1974 | 118 | 0.000 |
Why?
|
| Food Contamination | 1 | 1974 | 188 | 0.000 |
Why?
|
| Water Supply | 1 | 1974 | 213 | 0.000 |
Why?
|
| Pedigree | 1 | 1981 | 4637 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1983 | 2708 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1981 | 3194 | 0.000 |
Why?
|
| Seasons | 1 | 1974 | 1511 | 0.000 |
Why?
|
| Mutation | 1 | 1993 | 29981 | 0.000 |
Why?
|
| Sports | 1 | 1974 | 687 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1984 | 14219 | 0.000 |
Why?
|